In three out of four DBA patient samples, the erythroid maturation ratio (CD235a+ cells divided by total CD71+ cells) was significantly higher after hG1E-GATA1 treatment (Fig. 4G). This evidence concerns the gene TFRC and Diamond-Blackfan anemia.